Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3β-cyclin axis.

[1]  M. Humbert,et al.  2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.

[2]  J. Lorenzo,et al.  Kaempferol: A flavonoid with wider biological activities and its applications , 2022, Critical reviews in food science and nutrition.

[3]  B. Cockrill,et al.  Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. , 2022, JAMA.

[4]  Yongzhen Lu,et al.  A narrative review of research advances in hypoxic pulmonary hypertension , 2022, Annals of translational medicine.

[5]  Hong Yu,et al.  Integrated metabolomics and mechanism to reveal the protective effect of kaempferol on pulmonary arterial hypertension. , 2022, Journal of pharmaceutical and biomedical analysis.

[6]  F. Léon-Velarde,et al.  High-altitude erythrocytosis: mechanisms of adaptive and mal-adaptive responses. , 2022, Physiology.

[7]  Xin Zhao,et al.  Antioxidant and Inflammatory Effects of Nelumbo nucifera Gaertn. Leaves , 2021, Oxidative medicine and cellular longevity.

[8]  H. Ditzel,et al.  Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer , 2021, Nature Communications.

[9]  P. Siques,et al.  Oxidative Stress, Kinase Activation, and Inflammatory Pathways Involved in Effects on Smooth Muscle Cells During Pulmonary Artery Hypertension Under Hypobaric Hypoxia Exposure , 2021, Frontiers in Physiology.

[10]  Lianyu Chen,et al.  Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling , 2021, BMC Cancer.

[11]  Wenkai Yang,et al.  Kaempferol Alleviates Oxidative Stress and Apoptosis Through Mitochondria-dependent Pathway During Lung Ischemia-Reperfusion Injury , 2021, Frontiers in Pharmacology.

[12]  M. Rahmani,et al.  Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives , 2021, Cancers.

[13]  J. Zhai,et al.  Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/CDK6/cyclin D1 pathway. , 2021, European Review for Medical and Pharmacological Sciences.

[14]  H. Ghofrani,et al.  Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders , 2021, International journal of environmental research and public health.

[15]  Y. Qi,et al.  Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Rakesh Kundu,et al.  Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells. , 2020, Archives of biochemistry and biophysics.

[17]  G. Dianov,et al.  A unified model for the G1/S cell cycle transition , 2020, Nucleic acids research.

[18]  Wei Gao,et al.  Salidroside alleviated hypoxia-induced liver injury by inhibiting endoplasmic reticulum stress-mediated apoptosis via IRE1α/JNK pathway. , 2020, Biochemical and biophysical research communications.

[19]  Yan Jiang,et al.  Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension , 2020, Frontiers in Pharmacology.

[20]  Z. Bai,et al.  High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling. , 2020, Life sciences.

[21]  J. Y. Lee,et al.  Biventricular diastolic dysfunction, thrombocytopenia, and red blood cell macrocytosis in experimental pulmonary arterial hypertension , 2020, Pulmonary circulation.

[22]  W. El-Deiry,et al.  Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.

[23]  R. Rafikov,et al.  Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension , 2020, Antioxidants.

[24]  Jing Shi,et al.  Apigenin attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1α-KV1.5 channel pathway. , 2020, Chemico-biological interactions.

[25]  Wenkai Yang,et al.  Kaempferol Improves Lung Ischemia-Reperfusion Injury via Antiinflammation and Antioxidative Stress Regulated by SIRT1/HMGB1/NF-κB Axis , 2020, Frontiers in Pharmacology.

[26]  Rili Ge,et al.  Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat. , 2019, Journal of ethnopharmacology.

[27]  L. Lv,et al.  Omethoate induces pharyngeal cancer cell proliferation and G1/S cell cycle progression by activation of Akt/GSK-3β/cyclin D1 signaling pathway. , 2019, Toxicology.

[28]  Gang Fang,et al.  The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  M. Kamal,et al.  Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy. , 2019, Seminars in cancer biology.

[30]  G. Ji,et al.  Recent progress regarding kaempferol for the treatment of various diseases , 2019, Experimental and therapeutic medicine.

[31]  Kok-Gan Chan,et al.  Formononetin: A Review of Its Anticancer Potentials and Mechanisms , 2019, Front. Pharmacol..

[32]  Lijun Xue,et al.  Kaempferol Suppresses Proliferation and Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Breast Cancer Cells. , 2019, Oncology research.

[33]  B. Salehi,et al.  Kaempferol: A Key Emphasis to Its Anticancer Potential , 2019, Molecules.

[34]  C. Ruppert,et al.  Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension , 2019, Nature Communications.

[35]  A. Rauf,et al.  Chemo‐preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review , 2018, Phytotherapy research : PTR.

[36]  R. Roskoski.  Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. , 2019, Pharmacological research.

[37]  Rili Ge,et al.  Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells , 2018, BioMed research international.

[38]  Jiwang Chen,et al.  Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway , 2018, Nature Communications.

[39]  Dinesh Kumar,et al.  Kaempferol-induces vasorelaxation via endothelium-independent pathways in rat isolated pulmonary artery , 2018, Pharmacological reports : PR.

[40]  Liangxing Wang,et al.  Adenosine A(2A) receptor activation reverses hypoxia‑induced rat pulmonary artery smooth muscle cell proliferation via cyclic AMP‑mediated inhibition of the SDF1‑CXC4 signaling pathway. , 2018, International Journal of Molecular Medicine.

[41]  Rili Ge,et al.  Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. , 2018, Journal of ethnopharmacology.

[42]  Guogang Zhang,et al.  Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration , 2018, Cardiovascular research.

[43]  R. Mancinelli,et al.  Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases , 2017, Oxidative medicine and cellular longevity.

[44]  Lu Gao,et al.  Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice , 2017, Cellular Physiology and Biochemistry.

[45]  Liangxing Wang,et al.  Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2A receptor-induced SDF-1/CXCR4/PI3K/AKT signaling , 2017, Journal of Biomedical Science.

[46]  W. Seeger,et al.  Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs. , 2017, American journal of respiratory and critical care medicine.

[47]  Xianguang Fan,et al.  Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway. , 2016, Oncology reports.

[48]  R. Malhotra,et al.  Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats. , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[49]  Yun Liu,et al.  Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways. , 2016, The international journal of biochemistry & cell biology.

[50]  G. Shapiro,et al.  Targeting CDK4 and CDK6: From Discovery to Therapy. , 2016, Cancer discovery.

[51]  R. Brandes,et al.  Molecular mechanisms of hypoxia‐inducible factor‐induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension , 2016, The Journal of physiology.

[52]  Xia Fang,et al.  Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways , 2016, Journal of cardiovascular pharmacology.

[53]  L. Pan,et al.  Research on rat models of hypobaric hypoxia-induced pulmonary hypertension. , 2015, European review for medical and pharmacological sciences.

[54]  H. Ghofrani,et al.  Pathophysiology and Treatment of High-Altitude Pulmonary Vascular Disease , 2015, Circulation.

[55]  J. Garcia,et al.  Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[56]  P. Eshtehardi,et al.  Thrombocytopenia is an independent predictor of mortality in pulmonary hypertension. , 2014, Heart & lung : the journal of critical care.

[57]  J. Reusch,et al.  Inhibition of Phosphatidylinositol 3-kinase/Akt Signaling Attenuates Hypoxia-induced Pulmonary Artery Remodeling and Suppresses CREB Depletion in Arterial Smooth Muscle Cells , 2013, Journal of cardiovascular pharmacology.

[58]  Yong-ping Su,et al.  ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation , 2013, Cell Death and Disease.

[59]  Rainald Fischer,et al.  Hypobaric Hypoxia Causes Body Weight Reduction in Obese Subjects , 2010, Obesity.

[60]  R. Douglas,et al.  Differential effects of chronic intermittent and chronic constant hypoxia on postnatal growth and development , 2008, Pediatric pulmonology.

[61]  E. Walters,et al.  Phosphodiesterase 5 inhibitors for pulmonary hypertension , 2004 .

[62]  E. Papoutsakis,et al.  Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes , 2000, British journal of haematology.